These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15291672)

  • 1. Venlafaxine XR and chronic pelvic pain syndrome.
    Karp JF
    J Clin Psychiatry; 2004 Jun; 65(6):880-1. PubMed ID: 15291672
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
    Judge R; Wagner BE
    J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
    Feighner JP; Entsuah AR; McPherson MK
    J Affect Disord; 1998 Jan; 47(1-3):55-62. PubMed ID: 9476744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH; Salinas E
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ; Ventura D; Chang CC
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline versus venlafaxine XR in major depressive disorder.
    Lusicic A; Jagadheesan K
    J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
    Benedict A; Arellano J; De Cock E; Baird J
    J Affect Disord; 2010 Jan; 120(1-3):94-104. PubMed ID: 19497623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with venlafaxine and bupropion.
    Kirsch MA; Louie AK
    Am J Psychiatry; 1999 Mar; 156(3):494. PubMed ID: 10080572
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine versus sertraline for major depressive disorder.
    Wise TN; Sheridan MJ
    J Clin Psychiatry; 2000 Nov; 61(11):873-4. PubMed ID: 11105744
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.
    Bradley RH; Barkin RL; Jerome J; DeYoung K; Dodge CW
    Am J Ther; 2003; 10(5):318-23. PubMed ID: 12975715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
    Fava M; Mulroy R; Alpert J; Nierenberg AA; Rosenbaum JF
    Am J Psychiatry; 1997 Dec; 154(12):1760-2. PubMed ID: 9396960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine withdrawal reactions.
    Louie AK; Lannon RA; Kirsch MA; Lewis TB
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine versus fluoxetine.
    Paton C
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract]   [Full Text] [Related]  

  • 15. [Venlafaxine (velaxin) effectivity in treatment of depression: results of the recent investigations].
    Veltishchev DY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11 Pt 2):79-81. PubMed ID: 24429970
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.
    Gonul AS; Akdeniz F; Donat O; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):889-91. PubMed ID: 12921926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
    Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
    J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
    Vis PM; van Baardewijk M; Einarson TR
    Ann Pharmacother; 2005 Nov; 39(11):1798-807. PubMed ID: 16189284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.